Companies

Dr Reddy's launches Vigabatrin powder in US

Our Bureau Hyderabad | Updated on August 20, 2019 Published on August 20, 2019

Pharma major Dr. Reddy’s Laboratories Ltd has launched Vigabatrin Powder for Oral Solution in the US market.

It is a therapeutic equivalent generic version of Sabril (vigabatrin) Powder for Oral Solution approved by the US Food and Drug Administration (USFDA).

Dr. Reddy’s Vigabatrin Powder for Oral Solution is available in 500 mg per packet in count size of 50 per carton, according to a release.

Sabril is a trademark of Lundbeck. The Sabril brand and generic had US sales of approximately $274 million for the most recent twelve months ending in June 2019 according to IMS Health.

Published on August 20, 2019
This article is closed for comments.
Please Email the Editor